Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3899/jrheum.180251 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of Pseudochylothorax in a Patient with Lung Squamous Cell Carcinoma and Rheumatoid Arthritis.
Maedica (Bucur)
June 2024
Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Mito, Japan.
Pseudochylothorax is a rare disease entity. It is characterized by a milky white pleural fluid with a cholesterol/triglyceride ratio >1. According to published reports, most patients had associated diseases, including rheumatoid arthritis and tuberculosis, with only one patient having oropharynx carcinoma associated with lung metastases.
View Article and Find Full Text PDFA case report on chylothorax post penetrating chest trauma.
Int J Surg Case Rep
September 2023
Division of General Surgery, Department of General Surgery, Charlotte Maxeke Johannesburg Academic Hospital, 5 Jubilee Street, Parktown, Johannesburg, South Africa.
Introduction And Importance: Chylothorax is a rare condition secondary to a chyle leak from the thoracic duct. The most common cause is after thoracic and cardiac surgery. Other causes include malignancy, non-iatrogenic trauma, and miscellaneous disorder - tuberculosis, filariasis and idiopathic conditions.
View Article and Find Full Text PDFChocolate-Colored Pseudochylothorax in a Woman with a History of Pleuropulmonary Tuberculosis.
Am J Case Rep
June 2023
Department of Pneumology, University Hospital Pedro Ernesto, State University of Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
BACKGROUND Pseudochylothorax is a rare entity, with only a few hundred case reports worldwide. It presents as a pleural effusion rich in lipids, typically with a cloudy, milky appearance. The diagnosis is made based on the levels of cholesterol and triglycerides in the pleural fluid.
View Article and Find Full Text PDFThe laboratory investigation of pleural fluids: An update based on the available evidence.
Ann Clin Biochem
July 2023
Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
Selecting appropriate laboratory tests based on available evidence is central to improve clinical effectiveness and impacting on patient outcome. Although long studied, there is no mutual agreement upon pleural fluid (PF) management in the laboratory context. Given the experienced confusion about the real contribution of laboratory investigations to guide clinical interpretation, in this update, we tried to identify useful tests for the PF analysis, aiming to unravel critical points and to define a common line in requesting modalities and practical management.
View Article and Find Full Text PDF[Chinese expert consensus on diagnosis of pleural effusion].
Zhonghua Jie He He Hu Xi Za Zhi
November 2022
Pleural effusion(PE) is a common medical problem with various causes. The differential diagnosis for PE is often challenging. This consensus was generated by members of the academic group of the pleural and mediastinal diseases(preparatory) of Chinese Thoracic Society and some external experts.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!